Target intelligence / Profile preview

Cell wall biogenesis 43 C-terminal homolog (CWH43)

Target
CWH43
Molecular classification
Enzyme (lipid remodeling, GPI anchor maturation), Other (membrane and ER-associated protein)
01

Overview

Cell wall biogenesis 43 C-terminal homolog (CWH43) is a human enzyme localized to the endoplasmic reticulum and cell membrane, involved in lipid remodeling during the maturation of GPI-anchored proteins. It acts upstream of processes such as protein localization, and N-linked glycosylation, contributing to membrane protein trafficking and compartmentalization. CWH43 has been implicated as a tumor suppressor gene in colorectal cancer and can serve as a prognostic marker of disease progression. Protein coding defects in CWH43 are associated with rare diseases such as communicating hydrocephalus and Seckel syndrome 8. Its role is essential for proper protein anchoring and membrane structure, and dysfunction can lead to diverse developmental and oncologic pathologies.

Other names
PGAP2-interacting proteinCWH43PGAP2IPFLJ21511CWH43-CCell wall biogenesis protein 43 C-terminal homolog
02

Mechanism of action

For potential therapeutics targeting CWH43, postulated mechanisms may include: Modulation of lipid remodeling or GPI anchor maturation to affect membrane protein trafficking; Restoration or inhibition of CWH43 enzymatic activity in disease models (particularly cancer).

03

Biological functions

Lipid remodeling during GPI-anchor maturationGPI anchor biosynthetic processProtein localization and traffickingProtein N-linked glycosylationCellular compartmentalization (extracellular region and membrane, endoplasmic reticulum)
04

Disease associations

Cancer (notably colorectal cancer, where CWH43 acts as a tumor suppressor and is prognostic)Communicating hydrocephalusSeckel syndrome 8
05

Safety considerations

No specific safety concerns are documented for direct therapeutic targeting of CWH43; however, its role in essential lipid and protein modifications implies potential impact on broad cellular processes, warranting caution in targeting.
06

Biomarkers

CWH43 expression is proposed as a prognostic biomarker in colorectal cancer

Beyond the preview

Go deeper on Cell wall biogenesis 43 C-terminal homolog (CWH43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell wall biogenesis 43 C-terminal homolog (CWH43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call